The conclusion was to focus GRI support behind the development of the CrystaSulf process. It was decided to attempt to license the process since patent applications had been filed and a very good set of process data and thorough economic evaluations were in hand to facilitate a licensing technology transfer. Several firms were contacted who were known to be interested in this type of business opportunity for a variety of reasons. Confidentiality agreements were worked out to protect the patent position and technology transfer took place during the first half of the year. Ultimately, Radian International L.L.C., a joint venture company between DOW Chemical and Radian Corporation was awarded a non-exclusive, worldwide license to the GRI patents.
Additional licensees continue to be sought.
Under the terms of the GRI license, Radian will invest substantial funds of their own to further develop the technology and will construct and operate a pilot plant facility. The schedule anticipates plants being offered for commercial sale in 1999.